Objectives: 

1. Describe key advances shaping contemporary management of pediatric and adolescent Hodgkin Lymphoma.
2. Apply response- and Risk-adapted treatment principles to clinical decision making.
3. Discuss survivorship considerations that influence therapy selection and shared decision making.